“Lead Edge Capital’s investment propels our strategic vision and growth trajectory, allowing us to rapidly scale our presence, expand our product portfolio, and deliver flexible solutions to more healthcare institutions,” Tripp Higgins, CEO and co-founder of PaceMate, stated in a prepared statement. “As the pioneer in cardiac remote monitoring, we are elevating cardiac digital healthcare with data-rich and interoperable environments, integrating essential patient data in real-time to enhance efficiency and patient outcomes.”

“PaceMate delivers a powerful set of solutions focused on improving patient care and outcomes within the cardiac disease segment,” added Brian Neider, a associate with Lead Edge Capital. “Over the past several years, the company has worked tirelessly to deliver superior technology, service, and a level of care which has been unparalleled within the market. We are thrilled to partner with Tripp and the team on PaceMate’s next phase of growth.”

Financial phrases of the funding haven’t been made obtainable at the moment.

Click here for extra protection of PaceMate’s cardiac distant monitoring expertise.